The trial of Elizabeth Holmes resulted in a mixed verdict, but one outcome is clear: This was a big victory for prosecutors in a high-profile case where the defendant now faces a lengthy prison sentence.
Holmes’ conviction on four fraud charges involving huge sums of money invested in Theranos, the now-shuttered blood testing startup with Holmes at the helm, means she will likely spend many years behind bars. The three wire fraud counts accounted for more than $144 million in investments, a sum that will significantly drive up the length of her sentence, legal experts said. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. This name will appear with your comment
https://www.statnews.com/2022/01/04/elizabeth-holmes-theranos-fraud-investors/
